RaySearch Laboratories Gestion

Gestion contrôle des critères 3/4

Le PDG RaySearch Laboratories est Johan Lof, nommé en Jan2000, a un mandat de 24.83 ans. La rémunération annuelle totale est SEK 9.76M, composée du salaire de 66.2% et des bonus 33.8%, y compris les actions et options de la société. détient directement 16.08% des actions de la société, d'une valeur de SEK 1.14B. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 6.1 ans et 21.2 ans.

Informations clés

Johan Lof

Directeur général

SEK 9.8m

Rémunération totale

Pourcentage du salaire du PDG	66.2%
Durée du mandat du directeur général	24.8yrs
Propriété du PDG	16.1%
Durée moyenne d'occupation des postes de direction	6.1yrs
Durée moyenne du mandat des membres du conseil d'administration	21.2yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Johan Lof a-t-elle évolué par rapport aux bénéfices de RaySearch Laboratories?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Sep 30 2024	n/a	n/a	SEK 175m
Jun 30 2024	n/a	n/a	SEK 151m
Mar 31 2024	n/a	n/a	SEK 101m
Dec 31 2023	SEK 10m	SEK 6m	SEK 82m
Sep 30 2023	n/a	n/a	SEK 64m
Jun 30 2023	n/a	n/a	SEK 53m
Mar 31 2023	n/a	n/a	SEK 22m
Dec 31 2022	SEK 7m	SEK 6m	SEK 24m
Sep 30 2022	n/a	n/a	-SEK 6m
Jun 30 2022	n/a	n/a	-SEK 38m
Mar 31 2022	n/a	n/a	-SEK 35m
Dec 31 2021	SEK 7m	SEK 6m	-SEK 47m
Sep 30 2021	n/a	n/a	-SEK 46m
Jun 30 2021	n/a	n/a	-SEK 50m
Mar 31 2021	n/a	n/a	-SEK 42m
Dec 31 2020	SEK 7m	SEK 6m	-SEK 9m
Sep 30 2020	n/a	n/a	SEK 24m
Jun 30 2020	n/a	n/a	SEK 43m
Mar 31 2020	n/a	n/a	SEK 74m
Dec 31 2019	SEK 8m	SEK 6m	SEK 50m
Sep 30 2019	n/a	n/a	SEK 64m
Jun 30 2019	n/a	n/a	SEK 85m
Mar 31 2019	n/a	n/a	SEK 84m
Dec 31 2018	SEK 8m	SEK 5m	SEK 79m
Sep 30 2018	n/a	n/a	SEK 118m
Jun 30 2018	n/a	n/a	SEK 104m
Mar 31 2018	n/a	n/a	SEK 103m
Dec 31 2017	SEK 9m	SEK 5m	SEK 118m

Rémunération vs marché: La rémunération totale de Johan ($USD 893.16K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché UK ($USD 1.42M ).

Rémunération et revenus: La rémunération de Johan a augmenté de plus de 20 % au cours de l'année écoulée.

PDG

Johan Lof (55 yo)

24.8yrs

Titularisation

SEK 9,758,000

Compensation

Dr. Johan Lof has been the Chief Executive Officer and President of Raysearch Laboratories AB (Publ) since 2000. Dr. Lof serves as the Chief Executive Officer of RaySearch Medical AB. Dr. Lof has been a Di...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Johan Lof	Founder	24.8yrs	SEK 9.76m	16.08% SEK 1.1b
Bjorn Hardemark	Deputy Chief Executive Officer	9.2yrs	SEK 3.54m	0.018% SEK 1.2m
Annika Henriksson	Acting Chief Financial Officer	1.3yrs	pas de données	pas de données
Kjell Eriksson	Head of Research & Chief Science Officer	9.2yrs	pas de données	0.047% SEK 3.3m
Petra Jansson	General Counsel	7.3yrs	pas de données	pas de données
Peter Kemlin	Director of Sales & Marketing	no data	pas de données	0.0041% SEK 289.5k
Tove Alteborg	Global Human Resource Manager	1.3yrs	pas de données	pas de données
Fredrik Lofman	Head of Machine Learning	4.8yrs	pas de données	0.0041% SEK 289.5k
Marc Mlyn	President & CEO of RaySearch Americas	2.8yrs	pas de données	pas de données

6.1yrs

Durée moyenne de l'emploi

50.5yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de 0GRZ est chevronnée et expérimentée (6.1 années d'ancienneté moyenne).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Johan Lof	Founder	24.8yrs	SEK 9.76m	16.08% SEK 1.1b
Hans Wigzell	Independent Chairman of Board	20.5yrs	SEK 840.00k	pas de données
Carl Bergendal	Independent Director	24.8yrs	SEK 225.00k	3.39% SEK 240.4m
Radhe Mohan	Member of Scientific Advisory Board	21.8yrs	pas de données	pas de données
Anders Forsgren	Member of Scientific Advisory Board	no data	pas de données	pas de données
Anders Brahme	Member of Scientific Advisory Board	no data	pas de données	3.76% SEK 267.1m
David Jaffray	Member of Scientific Advisory Board	no data	pas de données	pas de données
Britta Wallgren	Independent Director	6.5yrs	SEK 300.00k	0.020% SEK 1.4m
Gunther Marder	Independent Director	2yrs	SEK 300.00k	0.20% SEK 14.5m

21.2yrs

Durée moyenne de l'emploi

70yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la 0GRZ est chevronné et expérimenté ( 21.2 années d'ancienneté moyenne).

RaySearch Laboratories Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

RaySearch Laboratories AB (publ) Announces CFO Changes

Insider recently sold kr630k worth of stock

Deputy Chief Executive Officer recently sold kr1.9m worth of stock

Henrik Bergentoft Leaves the Position as CFO for Raysearch

Founder recently sold kr40m worth of stock

Director recently bought kr88k worth of stock

Recent updates

RaySearch Laboratories AB (publ) to Report First Half, 2025 Results on Aug 07, 2025

Investor sentiment improves as stock rises 25%

RaySearch Laboratories AB (publ) to Report First Half, 2025 Results on Aug 08, 2025

RaySearch Laboratories AB (publ) Announces CFO Changes

Insider recently sold kr630k worth of stock

Deputy Chief Executive Officer recently sold kr1.9m worth of stock

RaySearch Laboratories AB (publ) to Report Q1, 2025 Results on May 09, 2025

Second quarter 2024 earnings released: EPS: kr1.79 (vs kr0.32 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

RaySearch to Present the Latest Advances in RayStation , RayCare and RayIntelligence At AAPM 2024

RaySearch Releases RayStation 2024B

RaySearch Laboratories AB (publ) Releases RayCare 2024A

Now 21% undervalued

Raysearch Laboratories AB (Publ) Apprves Ordinary Dividend for the Year 2023

First quarter 2024 earnings released: EPS: kr1.07 (vs kr0.51 in 1Q 2023)

Upcoming dividend of kr2.00 per share

Raysearch to Present the Latest Advances in Raystation, Raycare and Rayintelligence At Estro 2024

Investor sentiment improves as stock rises 18%

Full year 2023 earnings released: EPS: kr2.38 (vs kr0.69 in FY 2022)

New major risk - Revenue and earnings growth

RaySearch Laboratories AB (publ) Proposes an Extra Dividend for the Year Ended December 31, 2023, Payable on May 29, 2024

RaySearch Laboratories AB (publ) to Report Fiscal Year 2024 Results on Feb 14, 2025

RaySearch Laboratories AB (publ) Releases Raystation 2024A

Third quarter 2023 earnings released: EPS: kr0.63 (vs kr0.29 in 3Q 2022)

RaySearch Laboratories AB (publ) to Report Q2, 2024 Results on Aug 16, 2024

RaySearch to Showcase Latest Innovations in Raystation, RayCare and RayIntelligence to Be Presented at ASTRO 2023

RaySearch Laboratories AB (Publ) to Showcase the Latest Software Innovations At Astro in San Diego, California, October 1-4

RaySearch Laboratories AB (publ) to Report Fiscal Year 2023 Results on Feb 23, 2024

RaySearch Laboratories AB (publ) to Report Q1, 2024 Results on May 17, 2024

Second quarter 2023 earnings released

RaySearch to Present the Latest Advances in Raystation, RayCare and RayIntelligence at AAPM 2023

RaySearch Laboratories AB (Publ) Announces the Release of the Latest Version of RayCare®, the Next Generation Oncology Information System

RaySearch Laboratories AB (publ) Releases Raystation 2023B

Raysearch Laboratories AB (Publ)'s RayCare in clinical use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland

Henrik Bergentoft Leaves the Position as CFO for Raysearch

Founder recently sold kr40m worth of stock

New minor risk - Shareholder dilution

RaySearch Laboratories AB (publ) Announce to Exhibit Latest Software Innovations for Particle Therapy and BNCT at PTCOG 2023

First quarter 2023 earnings released

Director recently bought kr88k worth of stock

Founder recently sold kr1.1m worth of stock

Full year 2022 earnings released: EPS: kr0.69 (vs kr1.38 loss in FY 2021)

RaySearch Laboratories AB (publ) to Report Fiscal Year 2022 Results on Feb 28, 2023

RaySearch Laboratories AB (publ) to Report Q3, 2023 Results on Nov 17, 2023

Third quarter 2022 earnings released

High number of new directors

Raysearch Laboratories AB (Publ) Elects Günther Mårder as New Board Member

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Second quarter 2022 earnings released

Now 29% undervalued after recent price drop

Raysearch Laboratories AB (Publ) Appoints Henrik Bergentoft as Cfo, Effective from November 15, 2022

RaySearch Laboratories AB (publ) Launches RayStation 12A

RaySearch to Exhibit the Latest Software Innovations for Particle Therapy at PTCOG 2022

RaySearch Laboratories AB (publ) Releases Latest Version of RayCare

Founder recently sold kr20m worth of stock

First quarter 2022 earnings released

Raysearch Laboratories AB (Publ) Announces Raystation, Rayintelligence and Raycare to Be Presented At Estro 2022

Insufficient new directors

RaySearch Laboratories AB (publ) Announces Executive Changes

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Founder recently sold kr5.6m worth of stock

RaySearch AB (publ) Provides Cancer Clinics with User Configurable Workflows for Radiation Therapy

RayStation 11B Brings New Features for Adaptive Workflows, Brachytherapy, and Radiation Therapy with Ions

Third quarter 2021 earnings released

RaySearch Laboratories AB (publ) to Showcase Latest Innovations, RayIntelligence and RayCare at ESTRO 2021

Second quarter 2021 earnings released

Insufficient new directors